MLYS - Mineralys Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.00
DETAILS
HIGH:
$56.00
LOW:
$30.00
MEDIAN:
$52.00
CONSENSUS:
$46.00
UPSIDE:
54.10%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-18 | Rodman David Malcom | officer: Chief Medical Officer | SELL | 417 | $27.55 | $11K |
| 2026-05-18 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 417 | $15.44 | $6K |
| 2026-05-13 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 4,166 | $14.25 | $59K |
| 2026-05-11 | Rodman David Malcom | officer: Chief Medical Officer | SELL | 2,171 | $29.71 | $64K |
| 2026-05-12 | Rodman David Malcom | officer: Chief Medical Officer | SELL | 6,348 | $29.36 | $186K |
| 2026-05-12 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 6,348 | $1.08 | $7K |
| 2026-05-13 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 3,541 | $10.20 | $36K |
| 2026-05-11 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 2,171 | $16.00 | $35K |
| 2026-05-13 | Rodman David Malcom | officer: Chief Medical Officer | SELL | 14,056 | $28.58 | $402K |
| 2026-04-17 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 416 | $15.44 | $6K |
| 2026-04-17 | Rodman David Malcom | officer: Chief Medical Officer | SELL | 416 | $31.33 | $13K |
| 2026-04-13 | Congleton Jon | director, officer: Chief Executive Officer | SELL | 15,730 | $26.83 | $422K |
| 2026-04-13 | Rodman David Malcom | officer: Chief Medical Officer | SELL | 14,058 | $26.54 | $373K |
| 2026-04-15 | Rodman David Malcom | officer: Chief Medical Officer | SELL | 6,348 | $27.66 | $176K |
| 2026-04-13 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 6,349 | $1.08 | $7K |
| 2026-04-13 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 3,542 | $10.20 | $36K |
| 2026-04-13 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 4,167 | $14.25 | $59K |
| 2026-04-09 | Rodman David Malcom | officer: Chief Medical Officer | SELL | 2,170 | $27.38 | $59K |
| 2026-04-09 | Rodman David Malcom | officer: Chief Medical Officer | M-Exempt | 2,170 | $16.00 | $35K |
| 2026-03-31 | Congleton Jon | director, officer: Chief Executive Officer | SELL | 55,183 | $26.54 | $1.5M |
| 2026-03-31 | Karydas Daphne | director | M-Exempt | 3,000 | $12.02 | $36K |
| 2026-03-31 | Karydas Daphne | director | SELL | 3,000 | $25.00 | $75K |
| 2026-03-31 | Congleton Jon | director, officer: Chief Executive Officer | SELL | 19,364 | $25.50 | $494K |
| 2026-03-31 | Congleton Jon | director, officer: Chief Executive Officer | SELL | 453 | $27.05 | $12K |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. | director | BUY | 310,700 | $23.67 | $7.4M |